Seattle Genetics Inc (NASDAQ:SGEN)

36.25
Delayed Data
As of Feb 27
 -0.18 / -0.49%
Today’s Change
30.05
Today|||52-Week Range
55.99
+12.82%
Year-to-Date

Today’s Trading

Previous close36.43
Today’s open36.76
Day’s range35.73 - 37.89
Volume1,218,251
Average volume (3 months)1,361,619
Market cap$4.5B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-16.13%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.55-1.65%
ICPTIntercept Pharmaceut...+2.30+1.05%
----
AKRXAkorn Inc+0.34+0.64%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account